Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Novartis gets FDA panel backing for biosimilar Enbrel

However Amgen claims patent protection for the psoriatic arthritis therapy is valid until 2029

- PMLiVE

F2G appoints chief financial officer

Ralf Schmid brings experience from Nabriva Therapeutics

Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications

From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...

Lucid Group Communications Limited

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.

Lucid Group Communications Limited

- PMLiVE

Amgen’s Humira biosimilar moves closer to US approval

FDA committee backs company's version of AbbVie's blockbuster

- PMLiVE

Diabetes treatment ‘inextricably’ linked to patient education

Condition remains a significant burden for health systems

- PMLiVE

Takeda partners with Marvel for IBD superheroes

Will work with the entertainment firm's content marketing agency

- PMLiVE

Former Sanofi exec Joseph Devaney joins Astellas

He becomes government affairs and policy, Americas VP

National Institute for Health and Care Excellence NICE logo

NICE approves UCB Pharma’s Cimzia

New guidance could significantly extend the patient population it could treat

- PMLiVE

Hanover Comms collects Excellence in Public Health Comms award

Communiqué judges praise the #Savethemale campaign’s “sensitive” approach

- PMLiVE

Health Unlimited takes home Innovation award at Communiqué 2016

COPD Crowdshaped work for Novartis also wins excellence in a live event

Shire Basingstoke

FDA finally approves Shire’s potential blockbuster Xiidra

Dry eye disease treatment wins US licence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links